Skip to main content
. 2020 Sep 3;7(6):3633–3643. doi: 10.1002/ehf2.12883

FIGURE A1.

FIGURE A1

Proportion of patients on sacubitril/valsartan treatment reaching the specified doses during the study period (sacubitril/valsartan overall national cohort).

Note: X ‐axis shows groups of starting doses (any, 24/26, 49/51, and 97/103 mg). N, number of sac/val patients with minimum of two filled sac/val prescriptions and 6 months follow‐up. Last dose, last dose within 6 months; Max dose, max dose within 6 months